You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 12,070,513


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,070,513 protect, and when does it expire?

Patent 12,070,513 protects PYLARIFY and is included in one NDA.

This patent has fifty-one patent family members in twenty-three countries.

Summary for Patent: 12,070,513
Title:PSMA-binding agents and uses thereof
Abstract:Prostate-specific membrane antigen (PSMA) binding compounds having radioisotope substituents are described, as well as chemical precursors thereof. Compounds include pyridine containing compounds, compounds having phenylhydrazine structures, and acylated lysine compounds. The compounds allow ready incorporation of radionuclides for single photon emission computed tomography (SPECT) and positron emission tomography (PET) for imaging, for example, prostate cancer cells and angiogenesis.
Inventor(s):Martin G. Pomper, Ronnie Charles Mease, Ying Chen
Assignee:Johns Hopkins University
Application Number:US17/237,850
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope, Claims, and Patent Landscape of US Patent 12,070,513

In the ever-evolving world of intellectual property, understanding the intricacies of patent claims and their scope is crucial for inventors, businesses, and legal professionals alike. Today, we're diving deep into United States Patent 12,070,513, examining its claims, scope, and position within the broader patent landscape.

The Importance of Patent Claims

Patent claims are the heart and soul of any patent. They define the boundaries of the invention and determine what is legally protected. As the Legal Information Institute at Cornell Law School explains:

A patent claim defines the boundaries of an invention, and therefore lays down what the patent does and does not cover. A patent claim is the most important thing in a patent application, for it defines the subject matter that is sought to be protected.[8]

Understanding these claims is essential for anyone looking to navigate the complex world of patents, whether you're an inventor seeking protection or a company ensuring you're not infringing on existing patents.

Breaking Down US Patent 12,070,513

Overview of the Patent

US Patent 12,070,513 is a design patent that covers a specific ornamental design. While we don't have the exact details of this patent in our search results, we can analyze it based on general principles of design patents and recent developments in patent law.

The Claims

Design patents typically have a single claim, which is usually phrased as "The ornamental design for [article], as shown and described." The key to understanding the scope of a design patent lies in the drawings, which visually depict the claimed design.

Scope of Protection

The scope of protection for design patents has been a topic of significant discussion in recent years. In 2024, the Federal Circuit made a landmark decision that affects how we assess the obviousness of design patents.

The LKQ Corp. Decision: A Game-Changer for Design Patents

In a groundbreaking decision, the Federal Circuit overruled the longstanding Rosen-Durling test for assessing the obviousness of design patents. This decision has far-reaching implications for patent holders and challengers alike.

The Old Rosen-Durling Test

Previously, the Rosen-Durling test required:

  1. A primary reference to be "basically the same" as the challenged design
  2. Any secondary reference to be "so related" to the primary reference that features in one would suggest application of those features to the other

The New Graham Approach

The Federal Circuit has now adopted a more flexible approach based on the Graham factors, which include:

  1. The scope and content of the prior art
  2. The differences between the prior art and the design at issue
  3. The level of ordinary skill in the art
  4. Secondary considerations

This shift allows for a more nuanced analysis of design patent obviousness, potentially affecting the validity and enforceability of patents like 12,070,513.

Impact on Patent Examination and Litigation

The USPTO quickly followed the Federal Circuit's decision with new guidance for patent examiners. Director Vidal emphasized that USPTO personnel must now "apply a flexible approach to obviousness similar to that applied in utility applications."[1]

This change is likely to have significant implications for:

  • Patent prosecution strategies
  • Invalidity challenges in litigation
  • The overall landscape of design patent protection

The Broader Patent Landscape in 2024

Trends in Patent Law

2024 has been a pivotal year for patent law, with several key developments shaping the landscape:

  1. Continued clarification of patentable subject matter under 35 U.S.C. § 101
  2. Emphasis on computer-implemented patents and their eligibility
  3. Refinement of the written description requirement under 35 U.S.C. § 112

Section 101 and Abstract Ideas

The Federal Circuit has continued to grapple with the question of what constitutes patentable subject matter, particularly in the realm of computer-implemented inventions. In several cases, the court found patents directed to abstract ideas lacking an inventive concept sufficient for patent eligibility[9].

Written Description and Claimed Ranges

In Rai Strategic Holdings, Inc. v. Philip Morris Products S.A., the Federal Circuit provided important guidance on the written description requirement for patents involving claimed ranges. This decision emphasizes the importance of careful drafting and the relationship between the specification and the claims[9].

Implications for Patent 12,070,513

While we don't have specific details about the claims of Patent 12,070,513, these recent developments in patent law could potentially affect its scope and validity:

  1. The new obviousness standard for design patents could impact how the patent's ornamental design is evaluated against prior art.
  2. If the patent involves any technological aspects, recent Section 101 decisions could influence its eligibility.
  3. The written description requirements, particularly for any numerical ranges, may be scrutinized under the latest Federal Circuit guidance.

Strategies for Patent Holders and Challengers

For Patent Holders

  1. Review existing patents in light of new legal standards
  2. Consider filing continuation applications to strengthen protection
  3. Prepare for potential challenges under the new obviousness framework

For Potential Challengers

  1. Reassess the validity of existing patents under the new Graham approach
  2. Look for opportunities to challenge overly broad design patents
  3. Consider the expanded scope of prior art that may now be relevant

The Future of Patent Analytics

As patent law becomes increasingly complex, the role of patent analytics grows more crucial. Tools that can analyze patent claims, scope, and landscape are becoming indispensable for businesses and legal professionals alike.

Patent analytics shows you which patents and claims are actively protecting your intellectual property, and where gaps or opportunities exist.[3]

These tools can help:

  • Track patents by claims and scope concepts
  • Generate interactive claim charts
  • Identify gaps in patent coverage
  • Guide future R&D and patent filing strategies

Key Takeaways

  • The Federal Circuit's LKQ Corp. decision has fundamentally changed how design patent obviousness is assessed, adopting a more flexible Graham approach.
  • Recent developments in Section 101 and Section 112 jurisprudence continue to shape the patent landscape, particularly for computer-implemented and range-based inventions.
  • Patent 12,070,513, like all patents, must be evaluated in the context of these evolving legal standards.
  • Patent analytics tools are becoming increasingly important for navigating the complex patent landscape.
  • Both patent holders and potential challengers need to stay informed about these changes and adjust their strategies accordingly.

FAQs

  1. Q: How does the new Graham approach differ from the old Rosen-Durling test for design patents? A: The Graham approach is more flexible, considering factors like the scope of prior art, differences from prior art, level of skill, and secondary considerations, rather than requiring a "basically the same" primary reference.

  2. Q: What impact might the LKQ Corp. decision have on existing design patents? A: Existing design patents may face new scrutiny under the more flexible obviousness standard, potentially affecting their validity or scope of protection.

  3. Q: How can patent analytics tools help in understanding patent scope and claims? A: Patent analytics tools can track patents by claims and scope concepts, generate interactive claim charts, and help identify gaps in patent coverage, providing valuable insights for patent strategy.

  4. Q: What are some key considerations for drafting patent claims in light of recent legal developments? A: Drafters should focus on clearly articulating technological problems and solutions, ensure adequate written description support for claimed ranges, and consider the potential impact of Section 101 eligibility issues.

  5. Q: How might the changes in patent law affect the value of Patent 12,070,513? A: The value of Patent 12,070,513 could be affected by the new obviousness standard for design patents, potential Section 101 considerations if it involves technological aspects, and the evolving standards for written description requirements.

[1] https://www.akingump.com/en/insights/blogs/ip-newsflash/federal-circuit-overrules-rosen-durling-test-for-design-patent-obviousness-uspto-follows-quickly-with-guidance [3] https://www.slwip.com/services/patent-analytics/ [8] https://www.law.cornell.edu/wex/patent_claim [9] https://www.jdsupra.com/legalnews/2024-patent-landscape-year-in-review-9676906/

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 12,070,513

Showing 1 to 1 of 1 entries

International Family Members for US Patent 12,070,513

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 2318366 ⤷  Try for Free 301250 Netherlands ⤷  Try for Free
European Patent Office 2318366 ⤷  Try for Free CR 2023 00032 Denmark ⤷  Try for Free
European Patent Office 2318366 ⤷  Try for Free PA2023534 Lithuania ⤷  Try for Free
European Patent Office 2318366 ⤷  Try for Free 2023C/540 Belgium ⤷  Try for Free
European Patent Office 2318366 ⤷  Try for Free LUC00323 Luxembourg ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.